Breaking News

Amgen, DaVita Enter New Sourcing And Supply Agreement

Amgen will supply EPOGEN and Aranesp for dialysis services in the U.S. and Puerto Rico

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Amgen has entered into a six-year sourcing and supply agreement with DaVita, Inc., continuing its long-term relationship with DaVita focused on serving dialysis patients. Amgen will supply DaVita with EPOGEN (epoetin alfa) and Aranesp (darbepoetin alfa) to meet a specified annual percentage of DaVita’s requirements for erythropoiesis-stimulating agents used in providing dialysis services in the U.S. and Puerto Rico. The percentage varies during the term of the new agreement from Jan. 6,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters